+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Focused Ultrasound Tumor Therapeutic Systems Market by Type (High Intensity Focused Ultrasound, Low Intensity Focused Ultrasound), Technology (MRI Guided, Ultrasound Guided), System Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138600
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Focused Ultrasound Tumor Therapeutic Systems Market grew from USD 1.69 billion in 2024 to USD 1.81 billion in 2025. It is expected to continue growing at a CAGR of 7.15%, reaching USD 2.56 billion by 2030.

Pioneering the Future of Tumor Treatment with Focused Ultrasound Technologies That Are Reshaping Patient Outcomes and Clinical Possibilities

Focused ultrasound tumor therapy has emerged as a pioneering approach to treat solid tumors with precision and minimal invasiveness. By concentrating acoustic energy on targeted tissue masses, clinicians can achieve localized ablation, enhanced drug delivery, or neuromodulation without the collateral damage typically associated with conventional surgical or radiation modalities. This methodology leverages advanced imaging guidance to visualize the focal region in real time, enabling adjustments in energy dosage and targeting accuracy that adapt to each individual’s anatomical and pathological characteristics.

As healthcare systems increasingly prioritize patient-centric, value-based care, the appeal of focused ultrasound has grown. Its nonionizing nature offers an attractive safety profile compared to radiotherapy, while the outpatient potential and reduced recovery times align with cost containment imperatives. Furthermore, ongoing technical enhancements in transducer design, beamforming algorithms, and integration with magnetic resonance or diagnostic ultrasound platforms continue to expand clinical applications. Coupled with supportive preclinical and early clinical data, interest among oncologists, radiologists, and interventional specialists has surged, creating momentum for broader adoption.

Emerging Paradigm Shifts in Therapeutic Ultrasound That Are Accelerating Clinical Adoption and Driving Innovation Across Oncology Treatment Pathways

Rapid technological evolution and shifting clinical paradigms have propelled focused ultrasound into the mainstream of oncological interventions. Innovations in imaging integration have elevated the precision of targeting tumor tissues, enabling physicians to treat lesions in anatomically challenging regions such as the liver or pancreas with unprecedented accuracy. Simultaneously, breakthroughs in transducer materials and cooling systems have improved energy efficiency and reduced the risk of thermal damage to surrounding healthy structures.

Concurrently, regulatory bodies across multiple jurisdictions have issued more clearly defined pathways for device approval. This regulatory clarity has accelerated time to market for new systems and supported expanded indications. Additionally, interdisciplinary collaboration among radiology, oncology, and engineering specialists has fostered a fertile environment for translational research, leading to novel combinations of focused ultrasound with immunotherapy and targeted drug delivery strategies. These synergistic developments have collectively redefined therapeutic boundaries, suggesting that focused ultrasound will soon complement or even supplant traditional modalities in certain tumor types.

Analyzing the Cascading Effects of Recent United States Tariff Changes on Therapeutic Focused Ultrasound Supply Chains and Cost Structures

In 2025, the United States implemented revised tariff schedules affecting the import of therapeutic ultrasound components and complete systems. These measures have introduced upward pressure on manufacturing and acquisition costs, particularly for high intensity focused ultrasound modules and specialized imaging accessories sourced from international suppliers. As tariffs have increased the landed cost of transducer assemblies and precision electronics, both domestic producers and foreign exporters have had to reevaluate pricing models and supply chain logistics.

Consequently, providers have encountered budgetary challenges when procuring next-generation focused ultrasound units, prompting some to postpone capital investments or seek alternative financing arrangements. Manufacturers, in turn, are exploring strategies to mitigate cost impacts, including onshoring production of critical components, negotiating tariff carve-outs through trade agreements, and optimizing supply networks. Meanwhile, industry associations are engaging with policymakers to articulate the long-term benefits of these devices in reducing hospital stays and improving patient throughput. This ongoing dialogue suggests that future revisions to the tariff framework may incorporate exemptions or reductions tied to clinical outcome metrics.

Unveiling Critical Market Segmentation Dynamics Spanning Device Intensity Technology Application End User and System Configuration Dimensions

A multifaceted segmentation approach reveals diverse market dynamics across device intensity, guidance technology, and procedural modalities. When considering type, high intensity focused ultrasound encompasses both extracorporeal and intracorporeal configurations, while low intensity modalities support applications such as focused drug delivery and neuromodulation. This distinction underscores the importance of energy density and anatomical accessibility in device design.

Technology segmentation further differentiates systems by imaging modality. MRI guided platforms, available in closed bore and open bore architectures, deliver real-time thermal mapping and precise anatomical visualization, whereas ultrasound guided equipment offers rapid setup and logistical flexibility. Complementing these categories, system configuration insights highlight the coexistence of fixed and portable units, each tailored for distinct clinical environments and throughput requirements.

Finally, examining application and end user dimensions illuminates the market’s clinical reach. Therapeutic indications extend from bone metastases and uterine fibroids to primary tumors in the breast, liver, pancreas, and prostate. At the same time, device uptake occurs across ambulatory surgical centers, hospitals, research institutes, and specialty clinics, with imaging centers and oncology centers serving as specific subchannels within the specialty clinic segment. Together, these segmentation layers facilitate targeted development, commercialization, and adoption strategies.

Dissecting Regional Variations in Therapeutic Focused Ultrasound Adoption Highlighting Growth Drivers Regulatory Environments and Infrastructure Readiness

Regional market characteristics for therapeutic focused ultrasound vary significantly based on regulatory frameworks, healthcare infrastructure, and clinical expertise. In the Americas, well-established reimbursement policies and a strong culture of innovation have fostered rapid deployment of both high and low intensity systems. Clinical centers in the United States and Canada have been early adopters of MRI guided ablation, leveraging substantial research funding and private-public partnerships to advance trial protocols and center of excellence models.

Across Europe, the Middle East and Africa, adoption patterns reflect heterogeneous healthcare systems. Western European nations, supported by centralized approval mechanisms and reimbursement codes, have prioritized the introduction of portable focused ultrasound units within multidisciplinary oncology clinics. Meanwhile, emerging markets in the Middle East and Africa face infrastructure and training limitations but benefit from targeted investments in specialty centers aimed at oncology capacity building.

In Asia-Pacific, dynamic markets such as Japan, China and Australia are characterized by aggressive regulatory reforms and substantial capital infusion into medical technology. Governments and private healthcare providers are increasingly integrating focused ultrasound into national cancer plans, focusing on both fixed and hybrid portable systems. Strong clinical networks have enabled rapid knowledge transfer and local manufacturing initiatives, positioning the region as a critical growth frontier.

Profiling Leading Innovators and Strategic Collaborators Driving Competitive Differentiation in the Focused Ultrasound Tumor Therapy Ecosystem

Leading medical technology companies continue to differentiate through strategic partnerships, product portfolio expansion, and targeted clinical research. Firms specializing in high intensity devices are complementing their offerings with advanced extracorporeal transducers optimized for deep tissue penetration, while those focused on low intensity applications are pioneering drug encapsulation techniques and neuromodulation protocols.

Global platform providers are integrating artificial intelligence-enabled imaging analysis to automate treatment planning and real-time safety monitoring. Collaborative agreements between original equipment manufacturers and academic medical centers have accelerated the translation of novel focused ultrasound protocols into routine clinical practice. Additionally, alliances with pharmaceutical companies are reinforcing the role of focused ultrasound as an adjuvant to chemotherapy and immunotherapy regimens.

Smaller, agile innovators are carving out niches by introducing portable and cost-effective systems tailored for ambulatory settings and emerging markets. These companies emphasize modular architectures that can be upgraded via software enhancements, thereby extending device lifecycles. Collectively, these competitive movements underscore an ecosystem in which continuous innovation and value-added services serve as the primary differentiators.

Strategic Imperatives for Industry Leaders to Leverage Technological Synergies and Navigate Market Complexity for Sustained Competitive Advantage

Industry leaders should prioritize sustained investment in research and development to refine transducer efficiency and expand clinical indications. By forging alliances with imaging and pharmaceutical partners, they can accelerate the creation of combination therapies that leverage focused ultrasound’s unique mechanism of action. In parallel, companies must engage proactively with regulatory agencies to streamline approval pathways and advocate for favorable reimbursement policies grounded in health economic evidence.

Operational resilience can be enhanced through supply chain diversification, including nearshore manufacturing of critical components to mitigate tariff exposures and logistical disruptions. Equally important is the development of comprehensive training programs for clinicians and technicians, reinforcing best practices and ensuring consistent procedural outcomes. Leveraging digital tools such as remote monitoring platforms and AI-driven treatment planning can further elevate service offerings and support value-based contracting models.

Finally, organizations should adopt a segmented go-to-market approach, aligning product features and support services with the specific needs of distinct end user groups and regional markets. This customer-centric mindset will drive adoption, foster long-term partnerships, and establish focused ultrasound as an indispensable modality within the broader oncology care continuum.

Elucidating Rigorous Methodological Frameworks Employed for Comprehensive Focused Ultrasound Market Analysis Ensuring Data Integrity and Reliability

This research undertook a multi-layered methodological framework to ensure rigor and validity. Primary data were collected through expert interviews with key opinion leaders, including interventional radiologists, oncologists, health economists and procurement specialists. These qualitative insights were cross-validated against secondary data drawn from scientific publications, clinical trial registries and regulatory filings to corroborate device performance characteristics and approval timelines.

Quantitative analysis incorporated detailed mapping of product pipelines, competitive benchmarking and segmentation modeling. Segmentation variables were defined by device intensity, imaging modality, system configuration, clinical application and end user channel to generate nuanced market perspectives. Regional analysis accounted for healthcare expenditure trends, reimbursement policies and infrastructure maturity indices.

Data integrity was maintained through iterative triangulation, wherein conflicting findings prompted follow-up interviews and additional literature reviews. A peer-review process involving independent consultants and subject matter experts further refined assumptions and ensured objectivity. The resulting comprehensive dataset provides a transparent, reproducible foundation for strategic decision making and investment planning.

Synthesizing Core Insights on Technological Evolution Market Dynamics and Strategic Imperatives Shaping the Trajectory of Therapeutic Focused Ultrasound

The evolution of therapeutic focused ultrasound reflects a broader shift toward precision, minimally invasive oncology treatments. Technical advancements in energy delivery and imaging guidance have catalyzed new clinical applications, while regulatory clarity and reimbursement support continue to expand access. Tariff challenges underscore the importance of supply chain resilience and strategic advocacy to maintain affordability and growth momentum.

Segmented market analysis reveals distinct pathways for device developers, technology integrators and clinical adopters. Differences in device intensity, system architecture, application focus and end user requirements call for tailored commercialization strategies. Regional insights highlight the interplay between policy frameworks, infrastructure readiness and clinical expertise in shaping adoption trajectories.

Looking ahead, industry players that invest in collaborative research, diversify manufacturing footprints and engage proactively with key stakeholders will be best positioned to capitalize on this dynamic landscape. By aligning innovation efforts with unmet clinical needs and health economic imperatives, focused ultrasound can solidify its role as a transformative modality in the global fight against cancer.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • High Intensity Focused Ultrasound
      • Extracorporeal
      • Intracorporeal
    • Low Intensity Focused Ultrasound
      • Drug Delivery
      • Neuromodulation
  • Technology
    • MRI Guided
      • Closed Bore
      • Open Bore
    • Ultrasound Guided
  • System Type
    • Fixed Systems
    • Portable Systems
  • Application
    • Bone Metastases
    • Breast Cancer
    • Liver Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Fibroids
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Research Institutes
    • Specialty Clinics
      • Imaging Centers
      • Oncology Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • ALPINION MEDICAL SYSTEMS Co., Ltd.
  • Carthera S.A.
  • Chongqing Haifu Medical Technology Co Ltd.
  • EDAP TMS S.A.
  • GE HealthCare Technologies Inc.
  • HENZHEN PRO-HIFU MEDICAL TECH. CO., LTD.
  • HistoSonics, Inc.
  • INSIGHTEC Ltd.
  • Koninklijke Philips N.V.
  • Korust Co., Ltd.
  • NaviFUS Corp.
  • Neumous Inc.
  • OxSonics Therapeutics Ltd.
  • Profound Medical Corp.
  • Sonablate Corporation
  • SONIRE Therapeutics Inc.
  • SonoMotion, Inc.
  • THERACLION S. A.
  • Verasonics, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and real-time thermometry in focused ultrasound therapies
5.2. Advances in MR-guided focused ultrasound for targeted brain tumor treatment and barrier opening
5.3. Emergence of portable point-of-care focused ultrasound systems for outpatient oncology applications
5.4. High-intensity focused ultrasound devices advancing deep-seated pancreatic tumor ablation precision
5.5. Growing partnerships between pharmaceutical firms and focused ultrasound innovators for combination immunotherapy
5.6. Implementation of advanced transducer array designs to enhance penetration depth in solid tumor therapy
5.7. Adoption of closed-loop thermal feedback control systems to improve safety and efficacy in FUS treatments
5.8. Emergence of high-frequency transducer arrays improving focal spot resolution for minimally invasive tumor destruction
5.9. Regulatory approval of new microbubble agents boosting cavitation-mediated tumor cell disruption in clinical trials
5.10. Expansion of reimbursement frameworks supporting insurance coverage for noninvasive focused ultrasound tumor therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Focused Ultrasound Tumor Therapeutic Systems Market, by Type
8.1. Introduction
8.2. High Intensity Focused Ultrasound
8.2.1. Extracorporeal
8.2.2. Intracorporeal
8.3. Low Intensity Focused Ultrasound
8.3.1. Drug Delivery
8.3.2. Neuromodulation
9. Focused Ultrasound Tumor Therapeutic Systems Market, by Technology
9.1. Introduction
9.2. MRI Guided
9.2.1. Closed Bore
9.2.2. Open Bore
9.3. Ultrasound Guided
10. Focused Ultrasound Tumor Therapeutic Systems Market, by System Type
10.1. Introduction
10.2. Fixed Systems
10.3. Portable Systems
11. Focused Ultrasound Tumor Therapeutic Systems Market, by Application
11.1. Introduction
11.2. Bone Metastases
11.3. Breast Cancer
11.4. Liver Cancer
11.5. Pancreatic Cancer
11.6. Prostate Cancer
11.7. Uterine Fibroids
12. Focused Ultrasound Tumor Therapeutic Systems Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Research Institutes
12.5. Specialty Clinics
12.5.1. Imaging Centers
12.5.2. Oncology Centers
13. Americas Focused Ultrasound Tumor Therapeutic Systems Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Focused Ultrasound Tumor Therapeutic Systems Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Focused Ultrasound Tumor Therapeutic Systems Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ALPINION MEDICAL SYSTEMS Co., Ltd.
16.3.2. Carthera S.A.
16.3.3. Chongqing Haifu Medical Technology Co Ltd.
16.3.4. EDAP TMS S.A.
16.3.5. GE HealthCare Technologies Inc.
16.3.6. HENZHEN PRO-HIFU MEDICAL TECH. CO., LTD.
16.3.7. HistoSonics, Inc.
16.3.8. INSIGHTEC Ltd.
16.3.9. Koninklijke Philips N.V.
16.3.10. Korust Co., Ltd.
16.3.11. NaviFUS Corp.
16.3.12. Neumous Inc.
16.3.13. OxSonics Therapeutics Ltd.
16.3.14. Profound Medical Corp.
16.3.15. Sonablate Corporation
16.3.16. SONIRE Therapeutics Inc.
16.3.17. SonoMotion, Inc.
16.3.18. THERACLION S. A.
16.3.19. Verasonics, Inc.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET: RESEARCHAI
FIGURE 26. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET: RESEARCHSTATISTICS
FIGURE 27. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET: RESEARCHCONTACTS
FIGURE 28. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY INTRACORPOREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY INTRACORPOREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY NEUROMODULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY NEUROMODULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY CLOSED BORE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY OPEN BORE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY BONE METASTASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY BONE METASTASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 118. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 119. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 120. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 121. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 124. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 125. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 132. CANADA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 136. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 137. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 138. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 139. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 142. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 143. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 225. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 228. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 229. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 230. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 231. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 234. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 235. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. GERMANY FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 246. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 247. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 248. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY LOW INTENSITY FOCUSED ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 249. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
TABLE 252. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY MRI GUIDED, 2025-2030 (USD MILLION)
TABLE 253. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SYSTEM TYPE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. FRANCE FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA FOCUSED ULTRASOUND TUMOR THERAPEUTIC SYSTEMS MARKET SIZE, BY HIGH INTENSITY FOC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Focused Ultrasound Tumor Therapeutic Systems Market report include:
  • ALPINION MEDICAL SYSTEMS Co., Ltd.
  • Carthera S.A.
  • Chongqing Haifu Medical Technology Co Ltd.
  • EDAP TMS S.A.
  • GE HealthCare Technologies Inc.
  • HENZHEN PRO-HIFU MEDICAL TECH. CO., LTD.
  • HistoSonics, Inc.
  • INSIGHTEC Ltd.
  • Koninklijke Philips N.V.
  • Korust Co., Ltd.
  • NaviFUS Corp.
  • Neumous Inc.
  • OxSonics Therapeutics Ltd.
  • Profound Medical Corp.
  • Sonablate Corporation
  • SONIRE Therapeutics Inc.
  • SonoMotion, Inc.
  • THERACLION S. A.
  • Verasonics, Inc.

Table Information